Neither cohort showed any significant association of ovarian cancer with any of the other antibodies, Dr. Trabert said.
The NCI Intramural Research Program supported the study. Dr. Trabert and her colleagues declared no conflicts of interest.
SOURCE: Trabert et al. Abstract 4942.